With Alliance funding, a research study will analyze the differences in the colon microbiota in younger and older patients with colorectal cancer. Researchers increasingly believe microbiota has influence over human homeostasis and disease. Finding a link between changes in colon microbiota and colorectal cancer in young patients will guide future research in both preventative screening and treatment for young-onset colorectal cancer patients.
National nonprofit Colorectal Cancer Alliance conducted a survey of young-onset colorectal cancer survivors who were diagnosed with the disease prior to turning 50 years old. Results show a population of survivors who often faced barriers to screening due to their age, were most often misdiagnosed at the start of their journey, and then received a diagnosis of late-stage colorectal cancer—a disease that is highly treatable if caught early.
The Never2Young (N2Y) Advisory Board provides a strong voice for the young onset colorectal cancer community by going straight to the source: All of the members have been directly impacted by colorectal cancer, either as a survivor or patient. Members flew into Washington for the meeting from across the country.
The Colorectal Cancer Alliance convened the inaugural Never Too Young (N2Y) Advisory Board to address the concerns and needs of young colorectal cancer survivors, who are often overlooked due to their age because it’s typically seen in adults over 50 years old.
With the theme “Don’t Fumble On Getting Screened for Colon Cancer”, Baltimore Ravens third year tight end Maxx Williams will be wearing custom cleats during this Sunday’s game against the Detroit Lions to raise awareness about young onset colorectal cancer and in memory of his uncle, Paul “Chumly” Scheuble, who passed away this year from the disease at the age of 48.
Effective immediately, the Colon Cancer Alliance is now the Colorectal Cancer Alliance, embracing the entire colorectal cancer community, adopting a new name, and committing to a powerful mission: To empower a nation of allies who work with us to provide support for patients and families, caregivers, and survivors; to raise awareness of preventative measures; and inspire efforts to fund critical research. The official rebrand brings an inclusive identity that ensures accuracy, leadership, and most important- alliance within the colorectal cancer community.
VARUBI, a highly anticipated treatment for colorectal patients who suffer from delayed chemotherapy-induced nausea, has been approved by the Food and Drug Administration.
The Blue Hope Bash is the premiere fundraising gala of the Colon Cancer Alliance that brings together both individuals and corporations that are passionate about supporting our mission to end colon cancer within our lifetime.
Atlanta attorney Tawny Mack was a 21 year old college student when she first started experiencing colorectal cancer symptoms. Mack was attending a health and wellness presentation at her new firm when she started to seriously consider that colorectal cancer could be the cause for her symptoms. After scheduling a colonoscopy, Mack was diagnosed with stage 3c colorectal cancer at the age of 30.
The Colon Cancer Alliance’s annual National Conference will honor and celebrate colorectal patients and families, survivors, and caregivers. This two-day conference at the Cleveland Clinic in Cleveland, Ohio, is made up of those who have been personally affected by colorectal cancer in their lives.
According to a study in the Journal of the American Medical Association, colorectal cancers are on the rise in adults under the age of 55. However, the recommended age to begin screening for colorectal cancer is 50, unless you have a family history. With no family history of colorectal cancer, the potential for diagnosis flew under the radar for both Lucas and Egan.
It is with great enthusiasm that we welcome and congratulate the newly appointed Chairman, John Backus, our Vice Chair, Carmen Marc Valvo and our brand new members, David Schoeman and Lee Dranikoff. The accomplishments of these remarkable leaders cannot be overstated the entire Colon Cancer Alliance is thrilled to welcome them in their new roles.
The Colon Cancer Alliance is thrilled to announce the addition of two new members to the Board of Directors, David Schoeman, Senior Partner in the New York Office of McKinsey & Company, and Lee Dranikoff, Managing Director at American Studies. Both members have a personal understanding of colorectal cancer and its impact, which deepens their commitment to helping others affected and to one day finding a cure.
The event is in memory of prominent Washington, D.C. Attorney Mark Hulkower, who passed away from colon cancer in February 2011. The funds raised will support the Colon Cancer Alliance’s mission and national programs which champion prevention, fund cutting-edge research and provide the highest quality patient support services.
This year 95,520 people will be diagnosed with colon cancer and 50,260 will die from this disease. In Washington, 2,720 of the state’s residents have been diagnosed and 970 people have died as a result of colon cancer. The Colon Cancer Alliance is dedicated to doubling the number of patients and families served, investing $10 million in research and saving over 100,000 lives through increased screening over the next five years.
With double the engagement of any other online colorectal cancer community, along with the expertise of certified patient & family navigators managing communication, Blue Hope Nation is the best place to find hope, support, and answers.
The Alliance calls on Congress to engage with the broad health community to draft legislation that meaningfully improves access to care by increasing the number of Americans who have health insurance.
Colorectal Cancer Alliance receives recognition from Charity Navigator based on its rating in two broad areas of performance: Financial Health and Accountability and Transparency.
